RTY-694 is a potent, orally active ABCB4/BSEP positive functional modulator (PFM) that improves bile composition and enhances bile flow The differentiated mechanism of a dual-targeted ABCB4/BSEP PFM ...
BOSTON, May 27, 2026 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, a biotechnology company advancing Positive Functional Modulators (PFMs), a novel class of oral small molecules designed to restore and ...
Data highlight RTY-406's dual ABCB4/BSEP mechanism and marks the first demonstration of proof of mechanism in a non-human ...
RTY, Inc., has approached the city of New Philadelphia for financial assistance to maintain the rides at Tuscora Park. Maintenance costs have skyrocketed since Ohio passed Tyler's Law in 2019, which ...
CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., ("Rectify”) a biotechnology company developing positive functional modulators (PFMs), small molecule therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results